Haleon — A Cheap Consumer Staple?
Haleon ($HLN) is a new stock, created when pharmaceutical giant GlaxoSmithKline decided to spin-off their consumer healthcare sector.
Haleon focuses on making and selling over-the-counter medicines.
These are well-known products such as Advil and Excedrin pain relivers. Centrum vitamins. Sensodyne and Aquafresh toothpaste. Theraflu, Emergen-C, TUMs, ChapStick, and more.
Haleon’s over-the-counter healthcare portfolio makes up about $11.5 billion in collective annual sales.
This firm is much smaller than industry giants like Procter & Gamble or Colgate. But, Haleon owns a lot of popular household brands. And, the company trades cheaply compared to other consumer staples.
Haleon Stock Analysis
Haleon is a recent spin-off, and it’s a little hard to research all the details on this business. The company only started trading in July, so most of the usual metrics aren’t there — yet.
However, here’s what I was able to find:
Haleon currently trades at a share price of $6.33. And, the company has a PE ratio of about 17.
